首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1471953

藥物發現資訊學市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按工作流程、服務、解決方案、最終用戶和地理位置

Drug Discovery Informatics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow, Service, Solution, End User, and Geography

出版日期: 2024年03月18日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

2023年藥物發現資訊學市場價值為30.7億美元，預計到2031年將達到81.7億美元；預計2023-2031年複合年成長率為13.0%。

推動市場成長的關鍵因素是製藥公司對新藥分子研發的投資不斷增加，以及藥物發現和開發中計算和資訊工具的日益採用。然而，熟練技術人員的缺乏和軟體安裝成本高昂阻礙了藥物發現資訊學市場的成長。

藥物發現資訊學市場的市場趨勢：

在藥物開發和發現中部署人工智慧和機器學習 (ML) 演算法，透過提高這些過程的效率、速度和成功率，正在徹底改變藥物開發。這些技術用於分析大量資料、識別模式、預測分子相互作用並加速新候選藥物的發現。將人工智慧融入資訊科學所帶來的優勢大大增加了對計算工具、演算法和資料庫的需求，以發現和開發新的藥物分子。此外，醫療保健技術製造商正在市場上推出各種人工智慧整合解決方案；這對不斷成長的藥物發現資訊學市場規模做出了積極貢獻。例如，根據該公司新聞稿，默克於 2023 年 12 月推出了 AIDDISON 藥物發現軟體，這是一種結合藥物發現和合成的創新人工智慧解決方案。它是第一個軟體即服務平台，透過 Synthia 逆合成軟體 API 整合將虛擬分子設計和現實可製造性聯繫起來。

此外，領先的科技公司正在與學術機構合作開發用於藥物發現的資訊技術。例如，2023年1月，日立高新技術解決方案公司宣布與慶應義塾大學藥學院藥學系合作進行聯合研究，利用材料資訊學（MI）提高小分子藥物的開發效率。該團隊將利用化學資訊學（CI）MI工具開發傳統化學材料領域的材料以及藥物發現，以提高人們的生活品質（QoL）。

因此，藥物發現和產品發布方面的技術進步預計將在未來幾年帶來新的藥物發現資訊學市場趨勢。

藥物發現資訊學市場：細分概述

腫瘤生物相似藥根據藥物類別、癌症類型和配銷通路進行細分。

根據工作流程，市場分為發現資訊學和藥物開發。發現資訊學領域在2023 年佔據了更大的市場佔有率。。這對社會產生了顯著影響，特別是在寨卡病毒和武漢病毒爆發等國家和國際災難期間。由於接觸當前技術，資訊學工具和資料庫預計在未來幾年將大幅擴展。這些技術對於幫助公共衛生部門尋找新療法至關重要，而新療法預計將推動藥物發現資訊學市場的成長。

依服務分類，市場分為序列分析平台、分子建模、臨床試驗資料管理、對接等。序列分析平台領域預計將在 2023 年佔據最大的市場佔有率。

根據解決方案，藥物發現資訊學市場分為軟體和服務。到 2023 年，服務細分市場將佔據更大的藥物發現資訊學市場佔有率，預計 2023 年至 2031 年該細分市場的複合年成長率將更高。

根據最終用戶，市場分為製藥和生物技術公司、合約研究組織等。製藥和生物技術公司細分市場在 2023 年佔據最大市場佔有率。

藥物發現資訊學市場：地理概述

藥物發現資訊學市場報告的範圍涉及北美（美國、加拿大和墨西哥）、歐洲（西班牙、英國、德國、法國、義大利和歐洲其他地區）、亞太地區（韓國、中國、印度、日本、澳洲和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地區）。預計 2023 年至 2031 年，亞太地區的藥物發現資訊學市場複合年成長率最快。這是由於 Charles River Laboratories、Certara 和 Curia 等主要參與者的存在、傳染病的高發生率以及領先製藥公司和合約研究組織 (CRO) 快速採用新的先進研發工具等因素造成的。和開發。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 12 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第13章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 14 章：藥物發現資訊學市場 - 主要公司概況

Certara
Infosys Ltd
Collaborative Drug Discovery, Inc
Jubliant Biosys
Curia Global, Inc
Chemaxon Ltd
Charles River Laboratories
Agilent Technologies, Inc
Illumina, Inc
Boehringer Ingelheim International GmbH
Evotec

第 15 章：附錄

簡介目錄

Product Code: TIPHE100000965

The Drug discovery informatics market was valued at US$ 3.07 billion in 2023 and is expected to reach US$ 8.17 billion by 2031; it is estimated to record a CAGR of 13.0% during 2023-2031.

Key factors driving the market growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for drug discovery and development. However, the dearth of skilled technicians and the high cost of software setup hinder the drug discovery informatics market growth.

Market Trends of the Drug Discovery Informatics Market:

The deployment of AI and machine learning (ML) algorithms in drug development and discovery are revolutionizing drug development by enhancing these processes' efficiency, speed, and success rates. These technologies are used to analyze vast amounts of data, identify patterns, predict molecular interactions, and accelerate the discovery of novel drug candidates. The advantages offered by incorporating AI in informatics sciences have surged the demand for computational tools, algorithms, and databases to discover and develop new drug molecules. Additionally, healthcare technology manufacturers are launching various AI-integrated solutions in the market; this is positively contributing to the growing drug discovery informatics market size. For instance, as per the company press release, in December 2023, Merck introduced AIDDISON drug discovery software, an innovative AI solution that combines drug discovery and synthesis. It is the first software-as-a-service platform that bridges virtual molecule design and real-world manufacturability through Synthia retrosynthesis software API integration.

Additionally, leading tech companies are collaborating with academic institutions to develop information technology for drug discovery. For instance, in January 2023, Hitachi High-Tech Solutions Corporation announced the partnership with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences, to conduct joint research that will use Materials Informatics (MI) to enhance the efficiency of developing small molecule drugs. The team will leverage the Chemicals Informatics (CI) MI tool for developing materials in the traditional chemical materials field and also in drug discovery, with a view to improving the Quality of Life (QoL) for people.

Thus, such technological advancements in drug discovery and product launches are anticipated to bring new drug discovery informatics market trends in the coming years.

Drug Discovery Informatics Market: Segmental Overview

The oncology biosimilars are segmented based on drug class, cancer type, and distribution channel.

By workflow, the market is bifurcated into discovery informatics and drug development. The discovery informatics segment held a larger market share in 2023. The drug development segment is projected to register a higher CAGR from 2023 to 2031. The deployment of informatics tools and databases has significantly reduced the time to market for new therapies. This has remarkably impacted society, especially during national and international disasters, such as the Zika and Wuhan virus outbreaks. As a result of exposure to current technology, informatics tools, and databases are expected to expand enormously in the coming years. These technologies will be essential in helping the public health sector find novel therapies, which, in turn, is anticipated to propel the drug discovery informatics market growth.

The market, by service, is segmented into sequence analysis platforms, molecular modeling, clinical trial data management, docking, and others. The sequence analysis platform segment is anticipated to hold the largest market share in 2023. The molecular modeling segment is projected to register the highest CAGR from 2023 to 2031.

By solution, the drug discovery informatics market is segmented into software and services. The services segment held a larger drug discovery informatics market share in 2023, and the same segment is projected to register a higher CAGR from 2023 to 2031.

Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, and others. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2023. The contract research organizations segment is expected to register the highest CAGR from 2023 to 2031.

Drug Discovery Informatics Market: Geographical Overview

The scope of the drug discovery informatics market report entails North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific is expected to register the fastest CAGR in the Drug discovery informatics market from 2023-2031. This is attributed to factors such as the presence of major players, including Charles River Laboratories, Certara, and Curia, the high incidence of infectious diseases, and the rapid adoption of new and advanced R&D tools by leading pharmaceutical companies and Contract Research Organizations (CROs) for drug discovery and development.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Drug Discovery Informatics Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Drug Discovery Informatics Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Drug Discovery Informatics Market - Global Market Analysis

6.1 Drug Discovery Informatics - Global Market Overview
6.2 Drug Discovery Informatics - Global Market and Forecast to 2031

7. Drug Discovery Informatics Market - Revenue Analysis (USD Million) - By Workflow, 2021-2031

7.1 Overview
7.2 Discovery Informatics
7.3 Drug Development

8. Drug Discovery Informatics Market - Revenue Analysis (USD Million) - By Service, 2021-2031

8.1 Overview
8.2 Sequence Analysis Platform
8.3 Molecular Modeling
8.4 Clinical Trial Data Management
8.5 Docking
8.6 Others

9. Drug Discovery Informatics Market - Revenue Analysis (USD Million) - By Solution, 2021-2031

9.1 Overview
9.2 Software
9.3 Services

10. Drug Discovery Informatics Market - Revenue Analysis (USD Million) - By End User, 2021-2031

10.1 Overview
10.2 Pharmaceutical and Biotechnology Companies
10.3 Contract Research Organizations
10.4 Others

11. Drug Discovery Informatics Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

11.1 North America
- 11.1.1 North America Drug Discovery Informatics Market Overview
- 11.1.2 North America Drug Discovery Informatics Market Revenue and Forecasts to 2031
- 11.1.3 North America Drug Discovery Informatics Market Revenue and Forecasts and Analysis - By Workflow
- 11.1.4 North America Drug Discovery Informatics Market Revenue and Forecasts and Analysis - By Service
- 11.1.5 North America Drug Discovery Informatics Market Revenue and Forecasts and Analysis - By Solution
- 11.1.6 North America Drug Discovery Informatics Market Revenue and Forecasts and Analysis - By End User
- 11.1.7 North America Drug Discovery Informatics Market Revenue and Forecasts and Analysis - By Countries
  - 11.1.7.1 United States Drug Discovery Informatics Market
    - 11.1.7.1.1 United States Drug Discovery Informatics Market, by Workflow
    - 11.1.7.1.2 United States Drug Discovery Informatics Market, by Service
    - 11.1.7.1.3 United States Drug Discovery Informatics Market, by Solution
    - 11.1.7.1.4 United States Drug Discovery Informatics Market, by End User
  - 11.1.7.2 Canada Drug Discovery Informatics Market
    - 11.1.7.2.1 Canada Drug Discovery Informatics Market, by Workflow
    - 11.1.7.2.2 Canada Drug Discovery Informatics Market, by Service
    - 11.1.7.2.3 Canada Drug Discovery Informatics Market, by Solution
    - 11.1.7.2.4 Canada Drug Discovery Informatics Market, by End User
  - 11.1.7.3 Mexico Drug Discovery Informatics Market
    - 11.1.7.3.1 Mexico Drug Discovery Informatics Market, by Workflow
    - 11.1.7.3.2 Mexico Drug Discovery Informatics Market, by Service
    - 11.1.7.3.3 Mexico Drug Discovery Informatics Market, by Solution
    - 11.1.7.3.4 Mexico Drug Discovery Informatics Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

11.2 Europe
- 11.2.1 Germany
- 11.2.2 France
- 11.2.3 Italy
- 11.2.4 Spain
- 11.2.5 United Kingdom
- 11.2.6 Rest of Europe
11.3 Asia-Pacific
- 11.3.1 Australia
- 11.3.2 China
- 11.3.3 India
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 Rest of Asia-Pacific
11.4 Middle East and Africa
- 11.4.1 South Africa
- 11.4.2 Saudi Arabia
- 11.4.3 U.A.E
- 11.4.4 Rest of Middle East and Africa
11.5 South and Central America
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Rest of South and Central America

12. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

14. Drug Discovery Informatics Market - Key Company Profiles

14.1 Certara
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies